Skip to Content

Endo International PLC ENDP Stock Quote

| Rating as of

Morningstar‘s Stock Analysis ENDP

There is no Morningstar’s Analysis data available.

Key Statistics ENDP

Company Profile ENDP

Business Description

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.

Contact
Simmonscourt Road, Ballsbridge, First Floor, Minerva House
Dublin 4, Ireland
T +353 12682000
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Stock Type
Employees 3,103

Related News ENDP